Grants and Contributions:
Title:
Method Development to Support GLP Toxicology Studies of a Bone-Targeting Drug
Agreement Number:
954656
Agreement Value:
$180,000.00
Agreement Date:
Jul 10, 2020 - Mar 31, 2021
Description:
This project will help the firm qualify a non-rodent species for future IND-enabling safety studies by supporting the development of species-specific analytical methods as well as methods required for batch analysis and formulation development. It will also support preliminary pharmacological studies in the non-rodent species.
Organization:
National Research Council Canada
Expected Results:
The purpose of IRAP Contributions to Firms is to support research, development, adoption and/or adaptation of innovative or technology-driven new or improved products, services or processes in Canada up to their commercialization
Location:
Vancouver, British Columbia, CA V6T 1Z3
Reference Number:
172-2020-2021-Q2-954656
Agreement Type:
Contribution
Report Type:
Grants and Contributions
Recipient Business Number:
832032031
Recipient Type:
For-profit organization
Additional Information:
This agreement has been amended 1 time(s). The end date of this agreements has been modified by 12 days. The total amended value is 30,000 dollars.
Amendment Date
Mar 8, 2021
Recipient's Legal Name:
Mesentech Inc.
Federal Riding Name:
Vancouver Quadra
Federal Riding Number:
59039
Program:
Industrial Research Assistance Program – Contributions to Firms
Program Purpose:
The purpose of IRAP Contributions to Firms is to support research, development, adoption and/or adaptation of innovative or technology-driven new or improved products, services or processes in Canada up to their commercialization
Coverage:
IRAP Contributions to Firms projects stimulate wealth creation for Canada through technological innovation.
NAICS Code:
54171
Amendments: